Skip to content

Determine the effect of prescribing of misoprostol in reducing postpartum pregnancy and delivery success

Determining the effect of outpatient vaginal administration of misoprostol to reduce the rate of postpartum pregnancy and successful induction of labor

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180215038742N1
Enrollment
90
Registered
2018-04-09
Start date
2018-04-09
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-term Pregnancy. Post-term pregnancy

Interventions

Intervention 1: Intervention group: Vaginal misoprostol (25 micrograms) in pregnant women and membrane stripping. Intervention 2: Control group: membrane stripping.

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women with gestational age 39 weeks Primigravida Between 18 - 40 years old Singletone pregnancy Normal fetal heart rate Cephalic presentation (Vertex) AFI equal or more than 5 cm No history of medical or midwifery disorders Bishop score less than 8 Reactive NST Without uterine contractions

Exclusion criteria

Exclusion criteria: Macrosomia Sensitivity to PGs Uterin wall scar Preeclampsia or blood pressure more than 140/90 mmhg PROM Vaginal Bleeding IUGR fetus

Design outcomes

Primary

MeasureTime frame
Delivery rate before 41th week of gestational age. Timepoint: 39th week, 40th week and then every other day. Method of measurement: newborn birth.

Secondary

MeasureTime frame
Admission time to 2nd stage interval. Timepoint: Admission time and stage 2. Method of measurement: time interval (hour).;First administration to delivery interval. Timepoint: 39th week, delivery time. Method of measurement: time interval (hour).;Duration of stage 2. Timepoint: full diatation , fetal delivery. Method of measurement: time interval (min).;Additional interventions. Timepoint: Delivery time. Method of measurement: additional doses of oxytocin and misoprostol.;Final route of delivery. Timepoint: delivery time. Method of measurement: normal vaginal delivery or cesarian section duo to documents.;Maternal complication. Timepoint: delivery time. Method of measurement: Any complication that has been registered in the case file for the mother.;Apgar score. Timepoint: first and 5th minutes after delivery. Method of measurement: apgaar score scale.;Meconial staining. Timepoint: delivery time. Method of measurement: observation at delivery time.;Gestational age at admission. Timepoint: Admission time. Method of measurement: gestational age according first trimester sonography.;Bishop score at admission. Timepoint: admission time. Method of measurement: according to bishop score scale.;Additional dose of misoprostol or oxytocin. Timepoint: admission to delivery. Method of measurement: calculating additional dose of misoprostol or oxytocin.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Hadavi

Mashhad University of Medical Sciences

hadavif951@mums.ac.ir+98 51 3882 8888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026